
Contents
- 1 WHO launches updated clinical management guidance for COVID-19, including additional recommendation on stroke
- 2 Mechanical thrombectomy offers good value for money in Europe
- 3 SHOT CALLERS: A Virtual Event on COVID-19 Vaccines
- 4 Festive message from the SAFE team!
- 5 Hariklia Proios appointed new President of SAFE
WHO launches updated clinical management guidance for COVID-19, including additional recommendation on stroke
COVID-19 is associated with neurological manifestations, including stroke. In many cases, these have been reported even without respiratory symptoms. COVID-19 has been associated with acute cerebrovascular disease (including ischaemic and haemorrhagic stroke). ...

Mechanical thrombectomy offers good value for money in Europe
A paper published this month in Stroke Journal shows that treating all eligible patients with mechanical thrombectomy generated health and social care costs of €11 billion compared with €12 billion for current practice. Ramon Luengo-Fernandez and his team at the...

SHOT CALLERS: A Virtual Event on COVID-19 Vaccines
The European Patient Forum are hosting a event on all things related to the COVID-19 vaccines on Thursday, 28 January 2021 - 15:00-16:15 CET. The COVID-19 pandemic has led to the development and approval of new vaccines in a much shorter time-frame than usual. As a...

Festive message from the SAFE team!
We wish to extend out thanks for your continued support during a challenging year for us all. The pandemic has stretched healthcare systems to breaking point across Europe, touching everyone, including those affected by stroke. We now know much more about the link...

Hariklia Proios appointed new President of SAFE
At the SAFE General Assembly last month (November 2020), SAFE members appointed Hariklia Proios as the new President. Hariklia is has been on the SAFE board for three years and is the Vice President of the Hellenic Action for Stroke in Greece. We asked Hariklia about...